Hakutulokset - Mingyang Feng

Lenvatinib Plus Pembrolizumab vs. Chemotherapy in Pretreated Patients With Advanced Endometrial Cancer: A Cost-Effectiveness Analysis Tekijä Mingyang Feng, Mingyang Feng, Yue Chen, Yue Chen, Yang Yang, Yang Yang, Qiu Li, Qiu Li

Connect to this object online.

Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumor: A Systematic Review Tekijä Mingyang Feng, Mingyang Feng, Yang Yang, Yang Yang, Weiting Liao, Weiting Liao, Qiu Li, Qiu Li

Connect to this object online.

Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy Tekijä Shike Lou, Xiaoyin Wang, Fei Yuan, Gangde Zhao, Mingyang Feng, Yezhou Ding, Lanyi Lin, Kehui Liu, Xiaolin Wang, Wanqing Chi, Hui Wang

Connect to this object online.

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB Tekijä Shike Lou, Zhujun Cao, Wanqing Chi, Xiaoyin Wang, Mingyang Feng, Lanyi Lin, Yezhou Ding, Kehui Liu, Lihong Qu, Gangde Zhao, Shisan Bao, Hui Wang

Connect to this object online.